Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...

Analyst Josh Jennings from TD Cowen maintained a Hold rating on Edwards Lifesciences (EW – Research Report) and keeping the price target at ...

Edwards Lifesciences (EW) announced one-year data highlighting the continued performance of its SAPIEN 3 Ultra RESILIA valve. The data were ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

Edwards Lifesciences Co. (NYSE:EW – Free Report) – Zacks Research dropped their Q1 2025 EPS estimates for shares of Edwards ...

On Friday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $70.48 which represents a slight increase of $0.10 or 0.14% from the prior close of $70.38. The stock opened at ...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But in ...

Edwards Lifesciences Co. has a 52 week low of $58.93 and a 52 week high of $96.12. The company has a market cap of $41.01 billion, a PE ratio of 10.03, a P/E/G ratio of 3.81 and a beta of 1.12.

EW STOCK NEWS: Edwards Lifesciences Stock Plummeted 31% - Contact BFA Law About The Class Action Lawsuit If You Suffered Losses (NYSE:EW) ...

On Thursday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $70.38 which represents a slight increase of $0.84 or 1.21% from the prior close of $69.54. The stock opened at ...

Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic ...